Pharmaceutical

Cadonilimab by Akeso for Esophageal Squamous Cell Carci...

Dec 22, 2023

Cadonilimab is under clinical development by Akeso and currently in Phase II for...

SOR-007 by Nanology for Metastatic Adenocarcinoma of Th...

Dec 22, 2023

SOR-007 is under clinical development by Nanology and currently in Phase II for ...

MRNA-2752 by Moderna for Transitional Cell Cancer (Urot...

Dec 22, 2023

MRNA-2752 is under clinical development by Moderna and currently in Phase I for ...

Imvotamab by IGM Biosciences for Rheumatoid Arthritis: ...

Dec 22, 2023

Imvotamab is under clinical development by IGM Biosciences and currently in Phas...

XB-002 by Exelixis for Breast Cancer: Likelihood of App...

Dec 22, 2023

XB-002 is under clinical development by Exelixis and currently in Phase II for B...

Iruplinalkib by Qilu Pharmaceutical for Solid Tumor: Li...

Dec 22, 2023

Iruplinalkib is under clinical development by Qilu Pharmaceutical and currently ...

Runimotamab by Genentech USA for Solid Tumor: Likelihoo...

Dec 22, 2023

Runimotamab is under clinical development by Genentech USA and currently in Phas...

IDE-161 by Ideaya Biosciences for Metastatic Ovarian Ca...

Dec 22, 2023

IDE-161 is under clinical development by Ideaya Biosciences and currently in Pha...

Volrustomig by AstraZeneca for Cervical Cancer: Likelih...

Dec 22, 2023

Volrustomig is under clinical development by AstraZeneca and currently in Phase ...

IBI-322 by Innovent Biologics for Lymphoma: Likelihood ...

Dec 22, 2023

IBI-322 is under clinical development by Innovent Biologics and currently in Pha...

FDA approves AstraZeneca, Ionis treatment for rare nerve disease

FDA approves AstraZeneca, Ionis treatment for rare nerv...

Dec 21, 2023

The drug is a monthly injection for a genetic disorder called ATTR-PN, which aff...

Listen: 2023 in review, CEO report cards, and a look at...

Dec 21, 2023

This week on "The Readout LOUD": What does it mean to a bad CEO? Can biotech end...

Health data breaches hit an all-time high in 2023

Health data breaches hit an all-time high in 2023

Dec 21, 2023

At least 116 million individuals were impacted by large and numerous health data...

Morning Rounds: Why health care costs are nearly a fifth of the GDP

Morning Rounds: Why health care costs are nearly a fift...

Dec 21, 2023

Understand how science, health policy, and medicine shape the world everyday. Si...

BioMarin appeases an activist

BioMarin appeases an activist

Dec 21, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: FDA rejects Merck cough medicine; Sanofi abandons an ADC for lung cancer

STAT+: Pharmalittle: FDA rejects Merck cough medicine; ...

Dec 21, 2023

The FDA rejected Merck's treatment for chronic cough, saying the application "di...